Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CDKN1C Antikörper (AA 221-310)

CDKN1C Reaktivität: Human IF, ELISA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7148911
  • Target Alle CDKN1C Antikörper anzeigen
    CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))
    Bindungsspezifität
    • 16
    • 14
    • 11
    • 10
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 221-310
    Reaktivität
    • 98
    • 53
    • 22
    • 2
    Human
    Wirt
    • 64
    • 35
    Kaninchen
    Klonalität
    • 62
    • 37
    Polyklonal
    Konjugat
    • 49
    • 7
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CDKN1C Antikörper ist unkonjugiert
    Applikation
    • 42
    • 38
    • 33
    • 29
    • 22
    • 14
    • 14
    • 12
    • 8
    • 5
    • 4
    • 2
    • 1
    • 1
    Immunofluorescence (IF), ELISA
    Kreuzreaktivität
    Human
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human Cyclin-dependent kinase inhibitor 1C protein (221-310AA)
    Isotyp
    IgG
    Top Product
    Discover our top product CDKN1C Primärantikörper
  • Applikationshinweise
    Recommended dilution: IF:1:50-1:200,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))
    Andere Bezeichnung
    CDKN1C (CDKN1C Produkte)
    Synonyme
    BWCR antikoerper, BWS antikoerper, KIP2 antikoerper, WBS antikoerper, p57 antikoerper, p57Kip2 antikoerper, cb961 antikoerper, p27Xic1-a antikoerper, zgc:86618 antikoerper, AL024410 antikoerper, CDKI antikoerper, Kip2 antikoerper, p57(kip2) antikoerper, p57KIP2 antikoerper, cyclin dependent kinase inhibitor 1C antikoerper, cyclin-dependent kinase inhibitor 1Ca antikoerper, cyclin-dependent kinase inhibitor 1C (P57) antikoerper, cyclin-dependent kinase inhibitor 1C antikoerper, CDKN1C antikoerper, cdkn1ca antikoerper, Cdkn1c antikoerper
    Hintergrund

    Background: Potent tight-binding inhibitor of several G1 cyclin/CDK complexes (cyclin E-CDK2, cyclin D2-CDK4, and cyclin A-CDK2) and, to lesser extent, of the mitotic cyclin B-CDC2. Negative regulator of cell proliferation. May play a role in maintenance of the non-proliferative state throughout life.

    Aliases: Beckwith Wiedemann syndrome antibody, BWCR antibody, BWS antibody, CDKI antibody, CDKN 1C antibody, CDKN1C antibody, CDN1C_HUMAN antibody, Cyclin dependent kinase inhibitor 1C antibody, Cyclin dependent kinase inhibitor p57 antibody, Cyclin-dependent kinase inhibitor 1C antibody, Cyclin-dependent kinase inhibitor p57 antibody, KIP 2 antibody, KIP2 antibody, p57 antibody, p57 Kip 2 antibody, p57KIP2 antibody, WBS antibody

    UniProt
    P49918
    Pathways
    Zellzyklus, Dopaminergic Neurogenesis
Sie sind hier: